Riskpilot← Back to searchSign inGet full accessUroMedical Halland AB
ABActiveOrg 5567422786Skansgatan 1 BPhysiotherapy activities · NACE 8695Est. 200710 employees
Revenue 2025
SEK 25,3M
+5% vs 2024
EBITDA margin
18.8%
+1% vs 2024
Equity ratio
15.8%
Financial strength
Net profit 2025
SEK 0
+100% vs 2024
| Revenue | SEK 25,3M | +5% |
| EBITDA | SEK 4,7M | +1% |
| Net profit | SEK 0 | +100% |
| Total assets | SEK 11,2M | +37% |
| Equity | SEK 1,8M | +0% |
| Employees | 10 | — |
Legal name
UroMedical Halland AB
Org number
5567422786
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
8 november 2007
Share capital
SEK 100 000
Employees
10 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med suppleanten Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva medicinsk behandling, ergonomisk rådgivning, handel med värdepapper samt idka därmed förenlig verksamhet.
Address
Skansgatan 1 B
Email
maria.franlund@cmedical.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 18 780 | 15 839 | 16 613 | 17 936 | 19 509 | 22 823 | 24 081 | 25 319 |
| Staff expenses | — | — | — | — | — | — | — | −9 255 | −7 827 | −7 088 | −6 907 |
| EBITDA | 3 325 | 5 282 | 4 394 | 5 068 | 4 234 | 4 276 | 4 619 | 4 973 | 6 627 | 4 693 | 4 749 |
| Depreciation & amort. | −465 | −472 | −593 | −585 | −522 | −447 | −471 | −536 | −370 | −273 | −418 |
| EBIT | 2 860 | 4 810 | 3 801 | 4 483 | 3 712 | 3 829 | 4 148 | 4 437 | 6 257 | 4 420 | 4 330 |
| Net financials | 10 | 1 013 | −1 | −6 | −8 | 74 | 488 | 488 | 498 | −11 829 | 208 |
| Profit before tax | 2 497 | 9 069 | 3 801 | 4 477 | 3 704 | 2 837 | 2 957 | 1 669 | 2 | −7 409 | 0 |
| Tax | −563 | −1 787 | −837 | −988 | −794 | −613 | −610 | −344 | −2 | −956 | — |
| Net profit | 1 934 | 7 282 | 2 964 | 3 489 | 2 910 | 2 224 | 2 347 | 1 325 | 0 | −8 364 | 0 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8 183 | 11 316 | 8 343 | 6 379 | 7 896 | 11 021 | 14 954 | 19 771 | 14 397 | 8 160 | 11 200 |
| Equity | 3 548 | 8 930 | 4 293 | 4 819 | 4 239 | 6 464 | 8 811 | 10 136 | 10 136 | 1 772 | 1 772 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — |
| Short-term debt | 1 390 | 2 386 | 4 050 | 1 560 | 3 657 | 3 493 | 4 049 | 6 985 | 1 611 | 3 739 | 6 778 |
| Total debt | 1 390 | 2 386 | 4 050 | 1 560 | 3 657 | 3 493 | 4 049 | 6 985 | 1 611 | 3 739 | 6 778 |
EBITDA margin
18.8%
This company
15.8%
Market median
+19% vs market
20152025
Equity ratio
15.8%
This company
38.2%
Market median
-59% vs market
20152025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20152025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20152025
Asset turnover
2.26×
This company
1.12×
Market median
+102% vs market
20152025
Debt / equity
5.32×
This company
0.62×
Market median
-758% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BP Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
KK Chief Auditor | Chief Auditor | 2020 | — | — |
AM Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
RG Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2026 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Chairman | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
UroMedical Väst AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
UroMedical HoldCo AB
UroMedical Halland AB Board members of UroMedical Halland AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Börje Patrik Lennart Andius | Chief Executive Officer | 0 companies |
| Karin Kristina Eriksson | Chief Auditor | 0 companies |
| Anna Maria Kristina Frånlund | Chief Executive Officer | 0 companies |
| Robert Gelmanovski | Chief Executive Officer | 0 companies |
| Erik Rönnblad | Board of Directors | 0 companies |
| Thomas Haugen Skorpen | Deputy Board Member | 0 companies |
| Eskild Rudolf larsen | Chairman | 0 companies |
| Skorpen,Thomas Haugen | Deputy Board Member | 0 companies |
| Øyvind Bakke | Board of Directors | 0 companies |
| Gard Lauvsnes | Board of Directors | 0 companies |
| Fred Rosendal Helgesen | Chairman | 0 companies |
| Morten Henrik Greidung | Chairman | 0 companies |
| Patrik Bø Egeland | Board of Directors | 0 companies |
| Anna Ulrika Hansson | Board of Directors | 0 companies |
| Jan-Olof Wiklund | Deputy Board Member | 0 companies |
| Kurt Jonas Einar Hugosson | Board of Directors | 0 companies |
| Jonathan Kimber | Chairman | 0 companies |